ATR 1072 — IND submission
H2 2026
Submit IND application for ATR 1072 in the second half of 2026Source filing
ATRIUM THERAPEUTICS INC · Data as of 2026-09-08
H2 2026
Submit IND application for ATR 1072 in the second half of 2026Source filing
in 2027
File IND application for ATR 1086 in 2027, with IND-enabling studies initiating in 2026.Source filing
H2 2027
Report initial trial data from Corventis demonstrating proof of concept in the second half of 2027.Source filing